Latest News & Features
Americas
AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30. 3 December 2018
Big Pharma
Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations. 30 November 2018
Americas
The University of Wisconsin’s licensing arm has been ordered to pay Washington University $31.6 million in a fight over patent licensing relating to one of AbbVie’s kidney drugs. 30 November 2018
Biotechnology
The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug. 29 November 2018
Big Pharma
The US Food and Drug Administration has granted Pfizer paediatric exclusivity for Lyrica, extending the period of US market exclusivity for the drug by six months. 29 November 2018
Big Pharma
Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark 28 November 2018
Americas
California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California. 28 November 2018
Americas
The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years. 27 November 2018
Biotechnology
Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report. 27 November 2018
Asia-Pacific
India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma. 26 November 2018